Skip to content

Effects of Advance Care Planning on Patient Empowerment, Perception of Care and Healthcare Utilization in Older Patients with Multimorbidity: a Feasibility Pilot of a Randomized Controlled Trial

Effects of Advance Care Planning on Patient Empowerment, Perception of Care and Healthcare Utilization in Older Patients with Multimorbidity: a Feasibility Pilot of a Randomized Controlled Trial - Effects of ACP in Older Patients with Multimorbidity: a Feasibility Pilot

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON52742
Enrollment
50
Registered
2021-04-22
Start date
2021-05-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

zorggebruik healthcare utilization Patient empowerment

Interventions

One of the most well-researched ACP programs is the Respecting Choices Program. In this program, a trained facilitator encourages patients to reflect on their goals, values and beliefs, to discuss a

Sponsors

Department of Public Health, Section Care and Decision Making at the End of Life
Lead Sponsor

Eligibility

Age
65 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients >= 65 years of age with polypharmacy who gave informed consent and had 2 or more hospitalizations, day clinic admission or individual ER admissions in the last year

Exclusion criteria

Exclusion criteria: Patients with serious cognitive impairment (MMSE score

Design outcomes

Primary

MeasureTime frame
Trial-feasibility is defined as the successful inclusion of 50 patients in total, timely administration of the intervention in 25 patients, adherence to follow-up procedures and identification of problems or barriers during recruitment, inclusion, intervention administration and follow-up.

Secondary

MeasureTime frame
Our main outcome for cost-effectiveness is total duration and number of hospital admissions, as a proxy for both costs and effects (iMCQ). In order to inform a possible cost-effectiveness analysis (CEA), data on health-related quality of life (EQ5D-5L) will also be collected. Our outcomes for patient assessment of care and patient empowerment are the PACIC questionnaire, the ACP Engagement Survey and the appointment of a surrogate decision maker and/or the documentation of advance directives. Other data that will be collected to describe our population is daily activities (ADL and iADL) and destination at discharge (if admitted).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)